Close on 16 Oct 2026
All Indian Equities

CHANDAN HEALTHCARE

CHANDAN-SMVerified
ISIN: INECHANDA01010 · Exchange: NSE

CHANDAN HEALTHCARE is a publicly traded security listed on the NSE exchange.

Sector: Diversified Indian Equities·Industry: Public Market Listed Security·Market Cap: LARGE CAP
Close on 23 Oct 2026
₹218.60
-10.40 (-4.54%)
Last updated: 23 Oct 2026 (NSE/BSE EOD settlement)

Stock Snapshot & Key Numbers — CHANDAN HEALTHCARE

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Down -4.54% on 23 Oct 2026
Position vs 1-Year High
8.3% below 52W High
P/E Valuation Multiple
Not Reported / Loss
Annual Cash Dividend
0.00% / No Recent Dividend
Close on 23 Oct 2026
₹218.60
-10.40 (-4.54%)vs prev close
1-Year Low to High Range0% of range
Low: ₹219High: ₹238
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):N/A
P/B Ratio (Price / Book):N/A
Dividend Yield:0.00%
Total Company Value (Market Cap)
—
Sector: Diversified Indian Equities
Latest Official Announcement:Chandan Healthcare Limited Reports 46.66% YoY Growth in Q2 FY27 Diagnostics Revenue to Rs 56.38 Cr; Adds 410 Franchises - PNN Digital
11d ago
Plain-English Company Summary

CHANDAN HEALTHCARE (CHANDAN-SM) is a Indian equity security listed on the NSE with ISIN INECHANDA01010. As of the last recorded market session on Close on 23 Oct 2026, the stock closed at ₹218.60, recording a -10.40 (-4.54%) decline from its previous close of ₹229.00. Over the trailing 52-week trading cycle, CHANDAN-SM has traded between a 52-week low of ₹218.60 and a 52-week high of ₹238.40, establishing its annual trading channel. In historical performance, CHANDAN HEALTHCARE has fallen 6.98% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -8.31%, 1-month: -6.98%, 6-month: -6.98%, 1-year: -6.98%, 3-year: -6.98%, 5-year: -6.98%. Daily reported trading volume reached 36,000 equity shares. On key valuation multiples as of 25 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of data unavailable and a price-to-book (P/B) ratio of data unavailable, with a trailing dividend yield of 0.00%. Its market capitalization stands at —. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.

Price Chart

1Y: -6.98% (₹-16.40)
₹238₹232₹225₹219Fri, 9 Oct, 2026Fri, 23 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Channel₹218.60
Low: ₹218.6High: ₹238.4
Day Range₹213.75 – ₹235
Market Cap—
Reported Volume36,000
P/E Ratio (TTM)—
Price-to-Book (P/B)—
Dividend Yield0.00%
Fundamentals as of 25 Oct 2026

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹238.40₹218.60-8.31%
15 Days₹235.00₹218.60-6.98%
1 Month₹235.00₹218.60-6.98%
3 Months₹235.00₹218.60-6.98%
6 Months₹235.00₹218.60-6.98%
1 Year₹235.00₹218.60-6.98%
3 Years₹235.00₹218.60-6.98%
5 Years₹235.00₹218.60-6.98%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
—
Annualized volatility
1Y Beta vs Index
—
vs benchmark index
Biggest 1Y Drop
-8.3%
1Y peak-to-low drop
Biggest 5Y Drop
-8.3%
5Y peak-to-low drop
vs 52W High
-8.3%
Distance from 1Y high
vs 52W Low
+0.0%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹235.00₹218.60-7.0%

Historical Investment Simulator

Factual simulation of past returns in CHANDAN HEALTHCARE (CHANDAN-SM) using real recorded closing prices.

$10,000.00
5 Years
Principal Invested
$10,000.00
$10,000 initial capital
Portfolio Value Today
$9,486.60
Based on latest close
Absolute Return
-5.1%
-$513.40
Annualized (CAGR)
-74.7%
Annualized compound growth
Entry Price: $2.43 · Exit Price: $2.30
Simulated 5Y period (USD)

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for CHANDAN-SM.

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 5 of 6 Updates
#1 EARNINGSLODR Materiality: 99/100Positive Business DriverRecent EventDirect Mention
11d ago

Chandan Healthcare Limited Reports 46.66% YoY Growth in Q2 FY27 Diagnostics Revenue to Rs 56.38 Cr; Adds 410 Franchises - PNN Digital

Chandan Healthcare Limited Reports 46.66% YoY Growth in Q2 FY27 Diagnostics Revenue to Rs 56.38 Cr; Adds 410 Franchises PNN Digital

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Outlay:₹56.38 Cr
Inspecting in Causal Panel
Source: PNN Digital·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#2 EARNINGSLODR Materiality: 99/100Positive Business DriverBackground ContextDirect Mention
2mo ago

Chandan Healthcare Delivers Strong Q1 FY27; Total Income at 82 Cr, EBITDA Surges 42% YoY to 21 Cr, PAT Rises 30% YoY - https://www.indiagazette.com/

Chandan Healthcare Delivers Strong Q1 FY27; Total Income at 82 Cr, EBITDA Surges 42% YoY to 21 Cr, PAT Rises 30% YoY https://www.indiagazette.com/

Valuation Impact:+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Click to analyze
Source: https://www.indiagazette.com/·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#3 EARNINGSLODR Materiality: 86/100Neutral / RoutineBackground ContextDirect Mention
4mo ago

We Think That There Are Some Issues For Chandan Healthcare (NSE:CHANDAN) Beyond Its Promising Earnings - Simply Wall Street

We Think That There Are Some Issues For Chandan Healthcare (NSE:CHANDAN) Beyond Its Promising Earnings Simply Wall Street

Valuation Impact:±1.0% (In-line Quarterly Disclosure)
Click to analyze
Source: Simply Wall Street·Horizon: IMMEDIATE
SEBI LODR Reg 30 Mapped
#4 GENERALLODR Materiality: 68/100Neutral / RoutineOngoing ImpactDirect Mention
24d ago

Chandan Healthcare Enters Ghaziabad with Acquisition of Two Ansh Diagnostics Units - PNN Digital

Chandan Healthcare Enters Ghaziabad with Acquisition of Two Ansh Diagnostics Units PNN Digital

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: PNN Digital·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#5 GENERALLODR Materiality: 68/100Neutral / RoutineOngoing ImpactDirect Mention
1mo ago

Chandan Healthcare Scales Franchise Network to 500+ Franchises; Targets 1,000 Franchises by FY27-End - Ahmedabad Mirror

Chandan Healthcare Scales Franchise Network to 500+ Franchises; Targets 1,000 Franchises by FY27-End Ahmedabad Mirror

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: Ahmedabad Mirror·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 5
Causal Attribution in Focus
EARNINGS·11d ago
Verified Exchange / Wire Disclosure:
Chandan Healthcare Limited Reports 46.66% YoY Growth in Q2 FY27 Diagnostics Revenue to Rs 56.38 Cr; Adds 410 Franchises - PNN Digital
Source: PNN Digital·LODR Materiality: 99/100Tailwind₹56.38 Cr Outlay
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Quarterly Financial Milestone & Operating Margins
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. CHANDAN-SM Accretion
+2.5% to +6.5% (EBITDA Multiple Expansion Tailwind)
Causal Attribution Analysis:Direct Named Awardee

Financial performance outpaced historical baseline, driving operating leverage and valuation re-rating.

Extracted Factual Evidence:
  • •Transaction / financial magnitude identified at ₹56.38 Cr
  • •Direct quantitative change registered at 46.66%
  • •Financial performance and operating margins expanded ahead of consensus projections
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.

Order Book & Revenue Visibility

Identified project outlay of ₹56.38 Cr secures forward multi-quarter top-line visibility.

Affected Financial Metrics:
Operating EBITDA MarginRevenue VisibilityNet Income (PAT)
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

At-a-Glance Health & Momentum Check

Market Mood: Consolidation / Rangebound
News Activity
ACCELERATING
Recent announcement pace
Profit & Margin Trend
CONTRACTING
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Consolidation / Rangebound
Current market trend
News Tone
POSITIVE EXPANSION
Recent filing tone
What This Means(based on reported financials)

While recent announcements reflect past operations, profit margins and return on capital have been tightening as the business absorbs higher costs or new expansion spending.

Active Risk Flags & Monitoring Constraints
Elevated regulatory and disclosure event clustering in observation windowPrice testing 52-week support threshold with elevated trading volume

Peer & Sector Comparison — Next Research Steps

Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.

Explore All Equities
Same-Sector Peers
Diversified Indian Equities
No direct peers in sector coverage.
Same-Industry Peers
Industry Sub-Segment
No peer equities in this industry.
Also Viewed In Session
Recent History
Start browsing to build your active session footprint.

Common Questions About CHANDAN HEALTHCARE (CHANDAN-SM)

Key facts on CHANDAN-SM share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of CHANDAN HEALTHCARE (CHANDAN-SM)?

As of 23 Oct 2026, the official closing share price of CHANDAN HEALTHCARE (CHANDAN-SM) on NSE is ₹218.60 (-4.54% vs the previous close). Over the past 52 weeks, CHANDAN-SM has traded between a low of ₹218.60 and a high of ₹238.40, with a reported market capitalization of —.

What are the historical returns of CHANDAN HEALTHCARE (CHANDAN-SM)?

Based on split-adjusted closing prices through 23 Oct 2026, CHANDAN HEALTHCARE (CHANDAN-SM) recorded the following trailing price returns: 1 Week: -8.31% (from ₹238.40 to ₹218.60); 15 Days: -6.98% (from ₹235.00 to ₹218.60); 1 Month: -6.98% (from ₹235.00 to ₹218.60); 3 Months: -6.98% (from ₹235.00 to ₹218.60); 6 Months: -6.98% (from ₹235.00 to ₹218.60); 1 Year: -6.98% (from ₹235.00 to ₹218.60); 3 Years: -6.98% (from ₹235.00 to ₹218.60); 5 Years: -6.98% (from ₹235.00 to ₹218.60). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of CHANDAN HEALTHCARE (CHANDAN-SM)?

CHANDAN HEALTHCARE (CHANDAN-SM) currently trades at a trailing Price-to-Earnings (P/E) ratio of not applicable (or negative trailing earnings), a Price-to-Book (P/B) ratio of not reported, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).

How much would a past lump-sum or monthly SIP investment in CHANDAN-SM have grown?

Based on historical closing prices for CHANDAN HEALTHCARE (CHANDAN-SM): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹93,021.28 (-7.0% total return, -84.8% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹10,000.00) would be worth ₹9,302.13 (-7.0% absolute return). You can test custom amounts and holding periods in the interactive calculator above.